Literature DB >> 2553702

Beta 2-microglobulin enhances insulin-like growth factor I receptor levels and synthesis in bone cell cultures.

M Centrella1, T L McCarthy, E Canalis.   

Abstract

Beta 2-Microglobulin (beta 2m), a component of the major histocompatibility complex in chordates, has growth factor-like activity for cultured rat cells. We presently describe interactions between beta 2m and insulin-like growth factor I (IGF I) in osteoblast-enriched cultures. beta 2m increased DNA synthesis and was synergistic with IGF I. Affinity labeling revealed that beta 2m enhanced IGF I receptor number, and Northern analysis and radioimmunoassay showed that beta 2m increased steady state IGF I transcripts and medium IGF I polypeptide levels. These results indicate that the growth-promoting activity of beta 2m is mediated at least in part by regulating local IGF I binding and synthesis by skeletal cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553702

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Spinal cord compression in renal osteodystrophy.

Authors:  J D Macfarlane; A Minhas; K S Han; M Boekhout
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

Review 2.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

3.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

Review 4.  β2-Microglobulin-mediated signaling as a target for cancer therapy.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Sajni Josson; Hiromitsu Mimata; Leland W K Chung
Journal:  Anticancer Agents Med Chem       Date:  2014-03       Impact factor: 2.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.